September 2013 Dialogues in Dermatology Issue
Includes 3 Interviews:
by Adam J. Friedman, MD interviewed
by Maurice Thew, MD
Dermatological Manifestations of New Oncology Drugs
by Mario E. Lacouture, MD interviewed by
Jeremy Moss, MD
Enhancing Observational Skills
by Irwin M. Braverman, MD
interviewed by Lynda S. Kauls, MD
Target Audience: Dermatologists and other health care
professionals who wish to access and update their current knowledge of
Learning Objectives: At the conclusion of this learning
activity, participants should be able to:
1. Identify the key developments in nanotechnology for the
diagnosis and treatment of skin disease and the maintenance of skin
2. Identify preventive
measures to avoid cutaneous reactions to chemotherapy.
3. Describe how
visual training can improve observational skills.
CME credit is only available to purchasers. CME expires September
The American Academy of
Dermatology is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
American Academy of Dermatology designates this enduring material for a maximum
of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
AAD Recognized Credit Statement
Dialogues in Dermatology
is recognized by the American Academy of Dermatology for 2.00 AAD Recognized
Credits and may be used toward the AAD Continuing Medical Education Award.
Supported browsers: FireFox (3+),
Google Chrome (5+), Internet Explorer (7+), Safari (5+), Opera (10+).
Adobe Reader (or other PDF reader) to
view PDF files.